Hotspot mutations in BCMA extracellular domain lead to differential susceptibility to anti-BCMA targeted immunotherapies

Lee, H; Ahn, S; Maity, R; Leblay, N; Ziccheddu, B; Truger, M; Chojnacka, M; Cirrincione, A; Durante, M; Tilmont, R; Barakat, E; Poorebrahim, M; Landgren, O; Einsele, H; Alberge, JB; Keats, J; Rasche, L; Maura, F; Neri, P; Bahlis, N

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S48